Business

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult population.

Jan 23, 2025 - 02:44
 0
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult population. Read More
Read More

Tags:

Previous Article

Jamie Dimon calls Elon Musk the ‘Einstein’ of our time—said they reconciled and ...

Next Article

New Star Wars 'Prequel Pack' Launching Alongside Jedi Power Battles This Week

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Billionaire clans jostle for power in Italy’s reshaped banking sector

Billionaire clans jostle for power in Italy’s reshaped ...

Jan 17, 2025  0

Plunging German EV sales hampered Europe’s shift to electric vehicles in 2024

Plunging German EV sales hampered Europe’s shift to ele...

Jan 21, 2025  0

This User-Friendly H&R Block Software Package is Only $40, While Supplies Last

This User-Friendly H&R Block Software Package is Only $...

Jan 18, 2025  0